Abstract Purpose of Review The goal of this review is to summarize what is known about
pregnancy in women with chronic myeloid leukemia (CML): there are very few guidelines …

With survival expectation that of age-matched controls and given excellent response and
worldwide access to tyrosine kinase inhibitors (TKI), family planning is increasingly …

Background The aim of this study was to explore outcomes of planned pregnancy in female
patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitors (TKIs). Materials …

Chronic myeloid leukemia (CML) management during pregnancy is challenging. In this
retrospective study, hospital records of CML patients treated between 2000 and 2021 were …

PURPOSE The aim of the current work was to report the effect of imatinib on pregnancy in
patients with chronic myeloid leukemia (CML). METHODS Data were collected between …

Tyrosine kinase inhibitors (TKIs) are teratogenic. Chronic myeloid leukemia (CML) is
increasingly identified in younger patients who wish to conceive, the management of CML …

Since the introduction of tyrosine kinase inhibitors (TKIs) at the beginning of the millennium,
the outlook for patients with chronic myeloid leukemia (CML) has improved remarkably. As …

Background: Exposure to TKI has teratogenic effects in animal studies and humans. CML is
being identified in younger patients who need to continue treatment for long periods of time …

The success of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid
leukaemia (CML) has resulted in a return to a normal life expectancy for the majority of …

The overwhelming success of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid
leukemia (CML) patients has opened a discussion among medical practitioners and the lay …